- Home
- HCC vs ZLAB Comparison
HCC vs ZLAB Comparison
Compare HCC & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCC | ZLAB |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 2.6B |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | HCC | ZLAB |
|---|---|---|
| Price | $87.97 | $25.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $95.29 | $49.60 |
| AVG Volume (30 Days) | 510.2K | ★ 818.3K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.36% | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | ★ 3.03 | N/A |
| Revenue | ★ $1,310,043,000.00 | $460,156,000.00 |
| Revenue This Year | $59.95 | $9.75 |
| Revenue Next Year | $8.77 | $26.03 |
| P/E Ratio | $30.30 | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $60.70 | $15.96 |
| 52 Week High | $111.42 | $34.72 |
Technical Indicators
Market Signals| Indicator | HCC | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 33.65 | 56.31 |
| Support Level | $85.21 | $24.81 |
| Resistance Level | $92.19 | $27.22 |
| Average True Range (ATR) | 4.21 | 0.90 |
| MACD | -2.52 | -0.23 |
| Stochastic Oscillator | 2.32 | 51.30 |
Price Performance
Historical ComparisonAbout HCC Warrior Met Coal Inc.
Warrior Met Coal Inc produces and exports met or steelmaking coal, which is used as a component for steel production by metal manufacturers in Europe, South America, and Asia. The company is involved in longwall mining operations in its underground mines based in Alabama, Mine No. 4, Mine No. 7, and Blue Creek. Additionally, its natural gas operations remove and sell natural gas from owned and leased coal seams by reducing natural gas levels in its mines. The company generates revenue mainly through the production of steelmaking coal for sale to the steel industry. Geographically, the firm generates maximum revenue from its customers in Asia, followed by Europe, South America, and the United States.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.